Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Changjiang Qin

1PUBLICATIONS

1CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jun 01, 2022

PARP inhibitor olaparib enhances the efficacy of radiotherapy on XRCC2-deficient colorectal cancer cells.

Changjiang Qin, Zhiyu Ji, Ertao Zhai

Pageof 1

Frequent Collaborators

1 joint publications

Zhiyu Ji

Frequent Collaborators

1 joint publications

Zhiyu Ji

Top Related Videos

Evaluating <em>In Vitro</em> DNA Damage Using Comet Assay

Evaluating <em>In Vitro</em> DNA Damage Using Comet Assay

Published on : Oct 11, 2017

See more related videos

Top Related Videos

Evaluating <em>In Vitro</em> DNA Damage Using Comet Assay

Evaluating <em>In Vitro</em> DNA Damage Using Comet Assay

Published on : Oct 11, 2017

See more related videos